Return to search results
Bromocriptine mesylate
Bromocriptine Mesylate, sold under the brand name PARLODEL, is an oral prescription drug manufactured by ANI Pharmaceuticals, Inc. It comes in tablet form (2.5 mg) and capsule form (5 mg) for treating conditions like Parkinson's disease and high prolactin levels. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Bromocriptine Mesylate, sold under the brand name PARLODEL, is an oral prescription drug manufactured by ANI Pharmaceuticals, Inc. It comes in tablet form (2.5 mg) and capsule form (5 mg) for treating conditions like Parkinson's disease and high prolactin levels. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Bromocriptine mesylate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Bromocriptine mesylate — ANDA 077646 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077646"
}
]
|
| identifier | ANDA077646 |
| issued | 2016-09-16 |
| keyword |
[
"health-care",
"medications",
"pharmaceuticals",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Bromocriptine mesylate |
